Q: Could I get your opinion on Amarin, a small cap biotech stock?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: You were right about CXR.
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
Q: Is this a good opportunity at this time for a two year hold?
Q: I know you don't cover American stocks but was wondering if I could get your opinion on RAD.
Q: If I may follow up to today's question about celgene; how does the lack of a dividend paid by celgene bring you to recommend against moving towards a 5% position?
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Q: It appears that what Peter has anticipated for CXR is about to occur. Financial Post reported earlier today, in part: "Following previous efforts to retool its capital structure, Concordia is beginning a court proceeding under the Canada Business Corporations Act (CBCA). The company hopes to reduce its existing secured and unsecured debt obligations by more than $2 billion."
Q: I currently own a 3.5 % position in celgene. Yesterday's accouncement of a failure to proceed to a phase 3 drug trial has led to two analyst downgrades. The stock is down 6 percent pre market. Would you be comfortable, at this moment, to top up to 5%? Or do you see more downside for the company, and would prefer to let things settle.
Thank you
Karim
Thank you
Karim
Q: I know you're not a fan of the above stock, but I believe the earnings report is coming in early November. Does it look like it may improve for the next report or is more bad news coming?
thanks, Paul
thanks, Paul
Q: They seem to have bottomed out and are now moving up on increased volume
Would this be a time to enter a small position
Tfsa and ok with risk
Thank you
Would this be a time to enter a small position
Tfsa and ok with risk
Thank you
Q: Any updated comments now that they are FDA approved?
Q: Any reason for today's drop in the share price? Obamacare news?Thank you!
Q: A two part question so do dock me two credits:
1. GUD: just about of patience with this stock which is down 18% this year. I know Goodman's reputation, and they have plenty of cash, and it took Paladin a long time to pay off, but sales are minimal, and more significantly, there doesn't appear to be much going on. Can you give me a plausible reason to hang in?
2. Other than the REITS - csh, exe, nwh - and your fave SIS, is there anything worth considering in this sector in Canada, or should I turn to the U.S.? Tecsys is technically in the Tech sector but could you reasonably consider it a healthcare stock?
Thanks!
1. GUD: just about of patience with this stock which is down 18% this year. I know Goodman's reputation, and they have plenty of cash, and it took Paladin a long time to pay off, but sales are minimal, and more significantly, there doesn't appear to be much going on. Can you give me a plausible reason to hang in?
2. Other than the REITS - csh, exe, nwh - and your fave SIS, is there anything worth considering in this sector in Canada, or should I turn to the U.S.? Tecsys is technically in the Tech sector but could you reasonably consider it a healthcare stock?
Thanks!
Q: The last question about TCS was in July. Since then the stock has been on a tear. I am thinking about swapping out GUD and DR for TCS - I know TCS is considered tech - but I am looking at it as a quasi healthcare pick. Thanks for your current views.
Q: Good morning 5i,
I've held RX for a while and have been frustrated by its performance for some time. Thankfully the stock has been on the move up for the last 9 months. Today it finally reached my break even price and I'm strongly inclined to walk away with my original investment. Could you please provide your thoughts on the company, its current prospects, and if you would continue to ride the momentum or look to greener pastures?
Thank you again for your valuable advice!
I've held RX for a while and have been frustrated by its performance for some time. Thankfully the stock has been on the move up for the last 9 months. Today it finally reached my break even price and I'm strongly inclined to walk away with my original investment. Could you please provide your thoughts on the company, its current prospects, and if you would continue to ride the momentum or look to greener pastures?
Thank you again for your valuable advice!
Q: Have your thoughts on this company changed since your last comments?
Q: G&M is reporting the CFO is leaving Friday. This stock has been treading water (at best) for a while. Is it time to bail or hold on - Thanks for your excellent service
Q: I recently heard about this micro-cap company on Small Cap power, a small healthcare monitoring company with accelerating growth....What are your thoughts?
Q: With GUD adding to their position do you think CTX is worth a punt? Sort of like following Buffet, Warsaw and Sprott. Thanks. Rod
-
Chartwell Retirement Residences (CSH.UN $20.31)
-
CRH Medical Corporation (CRH $4.99)
-
Knight Therapeutics Inc. (GUD $6.35)
-
Savaria Corporation (SIS $25.39)
Q: I'm 47 and have a balanced portfolio. My 30 days has passed on CRH Medical capital loss - so I could buy it back. I currently hold SIS and GUD in healthcare - while holding CSH as real estate/healthcare. Healthcare represents 8% of my portfolio while real estate represents 3% with REITS such as CAR.UN CSH.UN HR.UN and small REI.UN. Should I relook at CRH or add another like SIA? COV is a little small for me, but looks interesting. I can wait until after October 25th to see how CRH reports.
Q: What is with this stock? Results have improved substantially in recent quarters but the stock grinds lower.